A Comparison of Two Injection Locations in Obese Patients Having Lower Leg/Foot Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01550094|
Recruitment Status : Completed
First Posted : March 9, 2012
Last Update Posted : October 14, 2015
|Condition or disease|
|Strain of Muscle and/or Tendon of Lower Leg Fracture of Lower Leg Crushing Injury of Lower Leg Fracture Malunion - Ankle and/ or Foot Complete Tear, Ankle and/or Foot Ligament Pathological Fracture - Ankle and/or Foot Loose Body in Joint of Ankle and/or Foot|
The purpose of this study is to compare two different techniques for placement of nerve blocks for your foot or ankle procedure. A nerve block involves injecting numbing medications around a nerve to decrease pain after surgery. An ultrasound machine is often used to help see the nerve before injecting the numbing medicine. When an ultrasound machine is used during a block it is called an ultrasound-guided block.
Many studies of ultrasound-guided nerve blocks have involved mostly thin patients, especially from foreign countries. This study is different because the investigators are looking at patients living in America with a body mass index (a measure of the amount of body fat a person has) of more than 35.
The Sciatic nerve is a large nerve that provides most of the feeling and all of the movement to the foot and ankle. The nerve travels under the back of the leg, and splits into two smaller nerves slightly above the knee.
|Study Type :||Observational|
|Actual Enrollment :||60 participants|
|Official Title:||Evaluation of Ultrasound-Guided Popliteal Sciatic Nerve Blockade in the Severely and Morbidly Obese Populations|
|Study Start Date :||March 2012|
|Actual Primary Completion Date :||October 2015|
|Actual Study Completion Date :||October 2015|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01550094
|United States, Louisiana|
|Ochsner Clinic Foundation|
|New Orleans, Louisiana, United States, 70121|
|Principal Investigator:||Jose Soberon, MD||Ochsner Health System|